BlackRock
SCPS

BlackRock’s Scopus BioPharma Inc. Common Stock SCPS Stock Holding History

BlackRock’s Portfolio SCPS Stock Details SCPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-36,675
Closed -$25K – 6060
2022
Q1 		$25K Buy
36,675
+17,147
+88% +$16.6K ﹤0.01% 5535
2021
Q4 		$32K Buy
19,528
+510
+3% +$1.55K ﹤0.01% 5485
2021
Q3 		$79K Buy
19,018
+17,750
+1,400% +$91.4K ﹤0.01% 5196
2021
Q2 		$9K Sell
1,268
-106,969
-99% -$761K ﹤0.01% 5344
2021
Q1 		$915K Buy
+108,237
New +$1.13M ﹤0.01% 4519

Other funds holding SCPS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MRCM
M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock's SCPS Position: Q2 2022 in Review

BlackRock sold out of Scopus BioPharma Inc. Common Stock (SCPS) in Q2 2022, closing a stake of 36,675 shares — an estimated $25K sold.

BlackRock first reported a position in SCPS in Q1 2021 and held it in 5 quarters. The position peaked at $915K in Q1 2021. 17 funds tracked by Wall St. Rank hold SCPS as of Q2 2022.

  • BlackRock reported no remaining Scopus BioPharma Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • BlackRock sold 36,675 Scopus BioPharma Inc. Common Stock shares in Q2 2022, an estimated $25K.
  • BlackRock first reported a position in Scopus BioPharma Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • BlackRock's Scopus BioPharma Inc. Common Stock position peaked at $915K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Scopus BioPharma Inc. Common Stock as of Q2 2022.

Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.